These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7106335)

  • 61. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Saccharose esters as new auxiliary substances in pharmacy. 3. Their use in ointment bases].
    Gruntová Z; Mandák M; Ducková K
    Cesk Farm; 1967 Jul; 16(6):263-8. PubMed ID: 6056214
    [No Abstract]   [Full Text] [Related]  

  • 63. Tacrolimus hydrate ointment inhibits skin plasma extravasation in rats induced by topical m-xylene but not capsaicin.
    Goto S; Kondo F; Ikai Y; Miyake M; Futamura M; Ito K; Sakamoto T
    Eur J Pharmacol; 2009 Apr; 608(1-3):91-6. PubMed ID: 19258015
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The comparative effects of tacrolimus and hydrocortisone in adult atopic dermatitis: an immunohistochemical study.
    Caproni M; Torchia D; Antiga E; Terranova M; Volpi W; del Bianco E; D'Agata A; Fabbri P
    Br J Dermatol; 2007 Feb; 156(2):312-9. PubMed ID: 17223872
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Changes in ion permeability of skin under the influence of ointment bases].
    KISS G
    Borgyogy Venerol Sz; 1958; 12(4-5):187-8. PubMed ID: 13607591
    [No Abstract]   [Full Text] [Related]  

  • 67. [Refractometric determination of the fat base content in emulsion ointments (author's transl)].
    Rudischer S; Bauer HJ
    Pharmazie; 1981; 36(7):477-9. PubMed ID: 7279999
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Regional differences in the in vitro penetration of hydrocortisone through equine skin.
    Mills PC; Cross SE
    J Vet Pharmacol Ther; 2006 Feb; 29(1):25-30. PubMed ID: 16420298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Ways to improve the technology for preparing ointments under field conditions].
    Chirkov AI; Sobolenko AK; Li VN; Shidlovskiĭ NP
    Voen Med Zh; 1991 Jun; (6):63-5. PubMed ID: 1949653
    [No Abstract]   [Full Text] [Related]  

  • 70. [Stability of prednisolone-urea ointments].
    Horsch W; Löschburg M
    Pharmazie; 1977 Oct; 32(10):622-3. PubMed ID: 607224
    [No Abstract]   [Full Text] [Related]  

  • 71. [Contribution to local topical therapy of mastodynia (author's transl)].
    Walther M
    Schweiz Rundsch Med Prax; 1981 Jul; 70(29):1304-9. PubMed ID: 7024977
    [No Abstract]   [Full Text] [Related]  

  • 72. Calmurid: a urea cream for the skin.
    Drug Ther Bull; 1971 Apr; 9(8):29-30. PubMed ID: 5580380
    [No Abstract]   [Full Text] [Related]  

  • 73. [Is there a demand for extemporaneously made hydrocortisone ointments?].
    Eklund LH; Halldén L; Juhlin L
    Lakartidningen; 1974 Apr; 71(15):1476-8. PubMed ID: 4826665
    [No Abstract]   [Full Text] [Related]  

  • 74. Nonsurgical removal of dystrophic nails utilizing urea ointment occlusion.
    Port M; Sanicola KF
    J Am Podiatry Assoc; 1980 Oct; 70(10):521-3. PubMed ID: 7229250
    [No Abstract]   [Full Text] [Related]  

  • 75. [RESULTS OBTAINED BY THE USE OF A DERMAL TERRAMYCIN-HYDROCORTISONE OINTMENT IN THE TREATMENT OF RHINITIS].
    CROZET A
    Rev Laryngol Otol Rhinol (Bord); 1964; 85():119-22. PubMed ID: 14129944
    [No Abstract]   [Full Text] [Related]  

  • 76. Simplified nail taping with urea ointment for nonsurgical nail avulsion.
    Averill RW; Scher RK
    Cutis; 1986 Oct; 38(4):231-3. PubMed ID: 3780302
    [No Abstract]   [Full Text] [Related]  

  • 77. [Which concentration of urea is necessary for external therapy?].
    Wohlrab W
    Dermatol Monatsschr; 1988; 174(2):94-8. PubMed ID: 3371519
    [No Abstract]   [Full Text] [Related]  

  • 78. [Modification of the stability of prednisolone by urea in ointments].
    Wolf B; Horsch W
    Dermatol Monatsschr; 1987; 173(3):131-4. PubMed ID: 3595927
    [No Abstract]   [Full Text] [Related]  

  • 79. [Hydrogen perioxide ointment in pharmacy prescription].
    Czerwenka G
    Pharm Prax; 1968; 1():23. PubMed ID: 5731386
    [No Abstract]   [Full Text] [Related]  

  • 80. [Aspetic filling of ointment tubes in prescription work].
    Sandell E; Ernerot L
    Sven Farm Tidskr; 1966 Mar; 70(9):258-9. PubMed ID: 5912272
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.